Clinical Trial Update: HF Prevalence and Evolution of HF in DM II Patients at High Risk

View source ↗

Summary

AstraZeneca-sponsored registry study assessing the prevalence and progression of heart failure in high-risk patients with type 2 diabetes mellitus; the study st…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heart Failure
• Type 2 Diabetes Mellitus

Snippet

Sponsor: AstraZeneca | Conditions: RELATED REGISTRY SEARCH | Status: COMPLETED